The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. by Gui Araujo (22170819)

“…Parameter values: interaction strengths were drawn from a half-normal distribution of zero mean and a standard deviation of 0.2, and strength for consumers was made no larger than the strength for resources. …”

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Modelled policy outcomes, with posterior values for individual nodes ranked from 1-5 across the parties - Green, Reform UK, Liberal Democrat, Conservative, and Labour, where 1 is the lowest rank and 5 is the highest. The parties are ranked for each policy node in the network (e.g., income tax), based on the direction of change (“performance indicator”) stated in the first column (e.g., lowest, highest, most, improvement). For example, a value of 5 for Green tax means that green tax is lowest under Reform UK’s policies, while a value of 1 means that green tax is highest under the Green Party’s policies.... by Richard Stafford (174326)

“…The parties are ranked for each policy node in the network (e.g., income tax), based on the direction of change (“performance indicator”) stated in the first column (e.g., lowest, highest, most, improvement). For example, a value of 5 for Green tax means that green tax is lowest under Reform UK’s policies, while a value of 1 means that green tax is highest under the Green Party’s policies. …”

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

Decreased <i>Notch3</i> asymmetry in <i>Nodal</i> mutants. by Tobias Holm Bønnelykke (20968460)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)